Harbour Capital Advisors, LLC
Source: SEC Form 13F · as of Mar 2026Harbour Capital Advisors, LLC holds 16 biotech & pharma companies tracked by BioSniper, totaling $29.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$29.1M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 15,310 | $14.1M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 9,666 | $3.4M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 5,994 | $2.6M |
| MRKMerck & Co., Inc. | 14,454 | $1.6M |
| JNJJOHNSON & JOHNSON | 5,851 | $1.3M |
| GEHCGE HealthCare Technologies Inc. | 12,660 | $904K |
| ABTABBOTT LABORATORIES | 8,376 | $768K |
| ABBVAbbVie Inc. | 3,627 | $727K |
| TRVITrevi Therapeutics, Inc. | 40,700 | $602K |
| NVSNovartis AG | 3,654 | $538K |
| AZNASTRAZENECA PLC | 2,724 | $534K |
| ACLXArcellx, Inc. | 3,825 | $440K |
| VKTXViking Therapeutics, Inc. | 12,765 | $437K |
| AMGNAMGEN INC | 1,221 | $422K |
| SNDXSyndax Pharmaceuticals Inc | 13,650 | $301K |
| RDYDR REDDYS LABORATORIES LTD | 21,450 | $275K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.